Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 8/20 | 0.59 |
| ▸ | PDE2A | O00408 | 2/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.37 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 4/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CASR | P41180 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6568317 | 1.00 | CETP (0.59) | CETPPDE2ATLR8TLR7HTR2A | |
| SCHEMBL6571560 | 0.93 | CETP (0.60) | CETPTLR8TLR7HTR2ASLC6A4 | |
| SCHEMBL6568883 | 0.93 | CETP (0.60) | CETPTLR8TLR7HTR2ASLC6A4 | |
| SCHEMBL6570310 | 0.89 | CETP (0.45) | CETPPDE2ATLR8TLR7HTR2A | |
| SCHEMBL6435457 | 0.87 | CETP (0.42) | CETPPDE2A | |
| SCHEMBL6063930 | 0.87 | CETP (0.42) | CETPPDE2A | |
| SCHEMBL994517 | 0.86 | CETP (0.41) | CETPPDE2ATLR8TLR7HTR2A | |
| SCHEMBL6274625 | 0.86 | CETP (0.41) | CETPPDE2ATLR8TLR7HTR2A | |
| SCHEMBL5671276 | 0.86 | CETP (0.40) | CETPPDE2ATLR8TLR7KCNH2 | |
| SCHEMBL1899039 | 0.86 | PDE2A (0.42) | CETPPDE2ACASRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1469831-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | Pfizer Products Inc. (US) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003063832-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | PFIZER PRODUCTS INC. (US) | 2003-08-07 | — | — | WO | disclosed |